Interesting and not at all surprising. There's something shifty about the way the company operates and shareholders are the last to find out what is actually going on. The FDA trail went cold long ago and this was never adequately (or at all) explained to shareholders. Still, they're kept the dream alive by jumping onto other opportunities and I've always made money owning the stock.
RCE Price at posting:
$1.18 Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)